Evidence map›Paper›PMID 25227710›Full record

ArticleInternational journal of cancer2015

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.

Anja Rudolph, Roger L Milne, Thérèse Truong, Julia A Knight, Petra Seibold, Dieter Flesch-Janys, Sabine Behrens, Ursula Eilber, Manjeet K Bolla, Qin Wang and 81 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Polygenic scores in cancer.Nature reviews. Cancer · 2023
    Review
  3. Article
  4. Field cancerization in breast cancer.The Journal of pathology · 2022
    Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Impact of Gene-Environment Interactions on Cancer Development.International journal of environmental research and public health · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

91 authors at 20 institutions in 14 countries.

Anja RudolphDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Roger L Milne
Thérèse Truong
Julia A Knight
Petra Seibold
Dieter Flesch-Janys
Sabine Behrens
Ursula Eilber
Manjeet K Bolla
Qin Wang
Joe Dennis
Alison M Dunning
Mitul Shah
Hannah R Munday
Hatef Darabi
Mikael Eriksson
Judith S Brand
Janet Olson
Celine M Vachon
Emily Hallberg
J Esteban Castelao
Angel Carracedo
Maria Torres
Jingmei Li
Keith Humphreys
Emilie Cordina-Duverger
Florence Menegaux
Henrik Flyger
Børge G Nordestgaard
Sune F Nielsen
Betul T Yesilyurt
Giuseppe Floris
Karin Leunen
Ellen G Engelhardt
Annegien Broeks
Emiel J Rutgers
Gord Glendon
Anna Marie Mulligan
Simon Cross
Malcolm Reed
Anna Gonzalez-Neira
José Ignacio Arias Perez
Elena Provenzano
Carmel Apicella
Melissa C Southey
Amanda Spurdle
kConFab Investigators
AOCS Group
Lothar Häberle
Matthias W Beckmann
Arif B Ekici
Aida Karina Dieffenbach
Volker Arndt
Christa Stegmaier
Catriona McLean
Laura Baglietto
Stephen J Chanock
Jolanta Lissowska
Mark E Sherman
Thomas Brüning
Ute Hamann
Yon-Dschun Ko
Nick Orr
Minouk Schoemaker
Alan Ashworth
Veli-Matti Kosma
Vesa Kataja
Jaana M Hartikainen
Arto Mannermaa
Anthony Swerdlow
GENICA-Network
Graham G Giles
Hermann Brenner
Peter A Fasching
Georgia Chenevix-Trench
John Hopper
Javier Benítez
Angela Cox
Irene L Andrulis
Diether Lambrechts
Manuela Gago-Dominguez
Fergus Couch
Kamila Czene
Stig E Bojesen
Doug F Easton
Marjanka K Schmidt
Pascal Guénel
Per Hall
Paul D P Pharoah
Montserrat Garcia-Closas
Jenny Chang-Claude
German Cancer Research Center · DEInstitute of Cancer Research · GBThe University of Melbourne · AUUniversity of Cambridge · GBKarolinska Institutet · SEUniversité Paris-Sud · FRMount Sinai Hospital · CAMayo Clinic in Florida · USThe Netherlands Cancer Institute · NLUniversitätsklinikum Erlangen · DEUniversity of Copenhagen · DKCancer Research UK · GBInstitute for Prevention and Occupational Medicine · DEQIMR Berghofer Medical Research Institute · AUSpanish National Cancer Research Centre · ESUniversity of California, Los Angeles · USUniversity of Eastern Finland · FIUniversity of Sheffield · GBCambridge University Hospitals NHS Foundation Trust · GBFundación Pública Galega de Medicina Xenómica · ES

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL BREAST CANCERU01CA069467 · NCI · CANCER CARE ONTARIO · PI ANDRULIS, IRENE L. · 1995 to 2010
$10.4M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
THE AUSTRALIAN BREAST CANCER FAMILY REGISTRYU01CA069638 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 1995 to 2010
$6.6M
A genome-wide association study for breast cancer in BRCA1 mutation carriersR01CA128978 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2008 to 2012
$4.8M
Integrative Molecular Epidemiology WorkshopR25CA174664 · NCI · AMERICAN ASSOCIATION FOR CANCER RESEARCH · PI Shelley S Tworoger · 2013 to 2026
$2.8M
Cancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 16561Cancer Research UK 16563Cancer Research UK 16565Cancer Research UK C12292/A11174Cancer Research UK C1281/A12014Cancer Research UK C1287/A10118Cancer Research UK C1287/A 10710Cancer Research UK C5047/A10692Cancer Research UK C5047/A15007Cancer Research UK C5047/A8384CIHRNCI NIH HHS 1U19 CA148065NCI NIH HHS 1U19 CA148112NCI NIH HHS 1U19 CA148537NCI NIH HHS CA128978NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA128978NCI NIH HHS R25 CA174664NCI NIH HHS RFA-CA-06-503NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA069467NCI NIH HHS U01 CA069638NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA69467NCI NIH HHS U01 CA69638NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS UM1 CA164920
6 · The paper itself

Abstract

A large genotyping project within the Breast Cancer Association Consortium (BCAC) recently identified 41 associations between single nucleotide polymorphisms (SNPs) and overall breast cancer (BC) risk. We investigated whether the effects of these 41 SNPs, as well as six SNPs associated with estrogen receptor (ER) negative BC risk are modified by 13 environmental risk factors for BC. Data from 22 studies participating in BCAC were pooled, comprising up to 26,633 cases and 30,119 controls. Interactions between SNPs and environmental factors were evaluated using an empirical Bayes-type shrinkage estimator. Six SNPs showed interactions with associated p-values (pint ) <1.1 × 10(-3) . None of the observed interactions was significant after accounting for multiple testing. The Bayesian False Discovery Probability was used to rank the findings, which indicated three interactions as being noteworthy at 1% prior probability of interaction. SNP rs6828523 was associated with increased ER-negative BC risk in women ≥170 cm (OR = 1.22, p = 0.017), but inversely associated with ER-negative BC risk in women <160 cm (OR = 0.83, p = 0.039, pint = 1.9 × 10(-4) ). The inverse association between rs4808801 and overall BC risk was stronger for women who had had four or more pregnancies (OR = 0.85, p = 2.0 × 10(-4) ), and absent in women who had had just one (OR = 0.96, p = 0.19, pint = 6.1 × 10(-4) ). SNP rs11242675 was inversely associated with overall BC risk in never/former smokers (OR = 0.93, p = 2.8 × 10(-5) ), but no association was observed in current smokers (OR = 1.07, p = 0.14, pint = 3.4 × 10(-4) ). In conclusion, recently identified BC susceptibility loci are not strongly modified by established risk factors and the observed potential interactions require confirmation in independent studies.

Indexed as

Gene-Environment InteractionGenetic Predisposition to DiseaseBreast NeoplasmsFemaleGenetic LociHumansPolymorphism, Single NucleotideReceptors, EstrogenRisk FactorsReceptors, Estrogenbreast cancergene-environment interactiongenetic susceptibilityrisk factor

Identifiers

PMID25227710
PMCPMC4289418
OpenAlexW1930047873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.